title: Expression of leptin and iNOS in oral melanomas in dogs.
abstract: BACKGROUND
  Oral melanoma (OM) in dogs is an aggressive malignancy, with clinical behavior resembling cutaneous melanomas in humans. Melanoma in humans is promoted by an inflammatory environment that is contributed to by leptin and inducible nitric oxide synthase (iNOS).
  
  
  OBJECTIVE
  To determine if the patterns of leptin and iNOS expression are similar in OM in dogs and cutaneous melanomas in humans.
  
  
  METHODS
  Twenty client-owned dogs.
  
  
  METHODS
  Retrospective case study. Immunostaining of the OM tumors from each dog was scored for percentage and intensity of leptin and iNOS expression. Mitotic index was used as an indicator of tumor aggression.
  
  
  RESULTS
  Leptin was detected in ≥75% of the tumor cells in specimens from 11 dogs. One tumor expressed leptin in ≤25% of the cells. The intensity of leptin expression was variable with 6, 9, and 5 cases exhibiting low-, moderate-, and high-intensity staining, respectively. OM with the lowest percentage of iNOS positive cells displayed the highest mitotic indices (P = .006, ANOVA).
  
  
  CONCLUSIONS
  The expression of leptin is a common finding in melanomas in dogs. These data suggest that the possibility of future clinical applications, such as measuring the concentrations of plasma leptin as a screening tool or leptin as a target for therapy. The relevance of iNOS is not as clear in dogs with OM, for which other directed therapeutics might be more appropriate.
authors.affiliation: Department of Melanoma Medical Oncology Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
authors.forename: V R
authors.initials: VR
authors.lastname: Greene
authors.forename: H
authors.initials: H
authors.lastname: Wilson
authors.forename: C
authors.initials: C
authors.lastname: Pfent
authors.forename: J
authors.initials: J
authors.lastname: Roethele
authors.forename: J
authors.initials: J
authors.lastname: Carwile
authors.forename: Y
authors.initials: Y
authors.lastname: Qin
authors.forename: E
authors.initials: E
authors.lastname: Grimm
authors.forename: J A
authors.initials: JA
authors.lastname: Ellerhorst
mesh_terms: D000818:Animals; D004283:Dog Diseases / Q000378:metabolism*; D004285:Dogs; D015971:Gene Expression Regulation, Enzymologic; D015972:Gene Expression Regulation, Neoplastic; D020738:Leptin / Q000235:genetics / Q000378:metabolism*; D008545:Melanoma / Q000378:metabolism / Q000662:veterinary*; D009062:Mouth Neoplasms / Q000378:metabolism / Q000662:veterinary*; D052247:Nitric Oxide Synthase Type II / Q000235:genetics / Q000378:metabolism*
chemical_list: D020738:Leptin; D052247:Nitric Oxide Synthase Type II
keywords: Adipokine; Inflammation; Mucosal tumor; Prognosis
references.citation: Vet Pathol. 2008 Nov;45(6):889-96
references.pmid: 18984791
references.citation: Mamm Genome. 2005 Mar;16(3):211-7
references.pmid: 15834638
references.citation: Vet Pathol. 2000 Nov;37(6):597-608
references.pmid: 11105949
references.citation: Oncol Rep. 2010 Apr;23(4):901-7
references.pmid: 20204272
references.citation: Vet Immunol Immunopathol. 2008 Jun 15;123(3-4):353-9
references.pmid: 18406470
references.citation: Vet Pathol. 2006 Mar;43(2):136-49
references.pmid: 16537931
references.citation: Vet J. 2013 May;196(2):226-30
references.pmid: 23069279
references.citation: Cell Immunol. 2008 Mar-Apr;252(1-2):139-45
references.pmid: 18289518
references.citation: Nitric Oxide. 2008 Sep;19(2):133-7
references.pmid: 18472017
references.citation: Int J Cancer. 2006 Aug 15;119(4):861-6
references.pmid: 16557582